# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-25-055221
Filing Date
2025-12-04
Accepted
2025-12-04 07:49:41
Documents
76
Period of Report
2025-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | cbio-20251202.htm iXBRL | 8-K | 75924
2 | EX-4.1 | exhibit41-crescentx2025pip.htm | EX-4.1 | 113358
3 | EX-10.1 | exhibit101crescent-paragon.htm | EX-10.1 | 24508
4 | EX-10.2 | exhibit102-crescentx2025pi.htm | EX-10.2 | 285674
5 | EX-10.3 | exhibit103-crescentx2025pi.htm | EX-10.3 | 164838
6 | EX-99.1 | exhibit991-crescentxkelunp.htm | EX-99.1 | 25853
7 | EX-99.2 | exhibit992-cbiopressrelease.htm | EX-99.2 | 39812
8 | EX-99.3 | crescentbiopharmaupdatee.htm | EX-99.3 | 73052
12 |  | cbio-20251202_g1.jpg | GRAPHIC | 152523
13 |  | crescentbiopharmaupdatee001.jpg | GRAPHIC | 119969
14 |  | crescentbiopharmaupdatee002.jpg | GRAPHIC | 323863
15 |  | crescentbiopharmaupdatee003.jpg | GRAPHIC | 76690
16 |  | crescentbiopharmaupdatee004.jpg | GRAPHIC | 51919
17 |  | crescentbiopharmaupdatee005.jpg | GRAPHIC | 89011
18 |  | crescentbiopharmaupdatee006.jpg | GRAPHIC | 70767
19 |  | crescentbiopharmaupdatee007.jpg | GRAPHIC | 103994
20 |  | crescentbiopharmaupdatee008.jpg | GRAPHIC | 149520
21 |  | crescentbiopharmaupdatee009.jpg | GRAPHIC | 122551
22 |  | crescentbiopharmaupdatee010.jpg | GRAPHIC | 90987
23 |  | crescentbiopharmaupdatee011.jpg | GRAPHIC | 117448
24 |  | crescentbiopharmaupdatee012.jpg | GRAPHIC | 100335
25 |  | crescentbiopharmaupdatee013.jpg | GRAPHIC | 135226
26 |  | crescentbiopharmaupdatee014.jpg | GRAPHIC | 98626
27 |  | crescentbiopharmaupdatee015.jpg | GRAPHIC | 59223
28 |  | crescentbiopharmaupdatee016.jpg | GRAPHIC | 124318
29 |  | crescentbiopharmaupdatee017.jpg | GRAPHIC | 137336
30 |  | crescentbiopharmaupdatee018.jpg | GRAPHIC | 144907
31 |  | crescentbiopharmaupdatee019.jpg | GRAPHIC | 130351
32 |  | crescentbiopharmaupdatee020.jpg | GRAPHIC | 136318
33 |  | crescentbiopharmaupdatee021.jpg | GRAPHIC | 122582
34 |  | crescentbiopharmaupdatee022.jpg | GRAPHIC | 140886
35 |  | crescentbiopharmaupdatee023.jpg | GRAPHIC | 127181
36 |  | crescentbiopharmaupdatee024.jpg | GRAPHIC | 114111
37 |  | crescentbiopharmaupdatee025.jpg | GRAPHIC | 87798
38 |  | crescentbiopharmaupdatee026.jpg | GRAPHIC | 145958
39 |  | crescentbiopharmaupdatee027.jpg | GRAPHIC | 125362
40 |  | crescentbiopharmaupdatee028.jpg | GRAPHIC | 90991
41 |  | crescentbiopharmaupdatee029.jpg | GRAPHIC | 116325
42 |  | crescentbiopharmaupdatee030.jpg | GRAPHIC | 55753
43 |  | crescentbiopharmaupdatee031.jpg | GRAPHIC | 118439
44 |  | crescentbiopharmaupdatee032.jpg | GRAPHIC | 122659
45 |  | crescentbiopharmaupdatee033.jpg | GRAPHIC | 154305
46 |  | crescentbiopharmaupdatee034.jpg | GRAPHIC | 126832
47 |  | crescentbiopharmaupdatee035.jpg | GRAPHIC | 123831
48 |  | crescentbiopharmaupdatee036.jpg | GRAPHIC | 120748
49 |  | crescentbiopharmaupdatee037.jpg | GRAPHIC | 95800
50 |  | crescentbiopharmaupdatee038.jpg | GRAPHIC | 99620
51 |  | crescentbiopharmaupdatee039.jpg | GRAPHIC | 102223
52 |  | crescentbiopharmaupdatee040.jpg | GRAPHIC | 124554
53 |  | crescentbiopharmaupdatee041.jpg | GRAPHIC | 163295
54 |  | crescentbiopharmaupdatee042.jpg | GRAPHIC | 137114
55 |  | crescentbiopharmaupdatee043.jpg | GRAPHIC | 124210
56 |  | crescentbiopharmaupdatee044.jpg | GRAPHIC | 98741
57 |  | crescentbiopharmaupdatee045.jpg | GRAPHIC | 97468
58 |  | crescentbiopharmaupdatee046.jpg | GRAPHIC | 91707
59 |  | crescentbiopharmaupdatee047.jpg | GRAPHIC | 110943
60 |  | crescentbiopharmaupdatee048.jpg | GRAPHIC | 170589
61 |  | crescentbiopharmaupdatee049.jpg | GRAPHIC | 118581
62 |  | crescentbiopharmaupdatee050.jpg | GRAPHIC | 98635
63 |  | crescentbiopharmaupdatee051.jpg | GRAPHIC | 45197
64 |  | crescentbiopharmaupdatee052.jpg | GRAPHIC | 116054
65 |  | crescentbiopharmaupdatee053.jpg | GRAPHIC | 105941
66 |  | image_0.jpg | GRAPHIC | 17512
67 |  | image_0a.jpg | GRAPHIC | 31339
68 |  | image_1.jpg | GRAPHIC | 10489
| Complete submission text file | 0001628280-25-055221.txt |  | 10077193

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cbio-20251202.xsd | EX-101.SCH | 1800
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cbio-20251202_lab.xml | EX-101.LAB | 21885
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cbio-20251202_pre.xml | EX-101.PRE | 12520
78 | EXTRACTED XBRL INSTANCE DOCUMENT | cbio-20251202_htm.xml | XML | 2716

Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 251548297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)